TCT-404 First-in-Man Use of Novel Catheter-Based Intramyocardial Injection Platform X-DROP for Endocardial Alginate-Hydrogel Injection in the Treatment of Heart Failure

Bo Wang, Shuo Wang, Chao Gao, D. Scott Lim, Rutao Wang, Xin Meng, Ying Liu, Chao Zhu, Yoshinobu Onuma, Yunbing Wang, Patrick W. Serruys, Runlin Gao, R J Lee, Ling Tao

Article2023

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Bei Wang, Richard Lee, Chao Zhu, Chao Gao, R T Wang, Xin Meng, Patrick W. Serruys, Ling Tao

European Heart Journal

Article2003

Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure

Pieter C. Smits, Robert‐Jan van Geuns, Don Poldermans, Manolis Bountioukos, Emile Onderwater, Chi‐Hang Lee, Alex P.W.M. Maat, Patrick W. Serruys

Journal of the American College of Cardiology

TCT-404 First-in-Man Use of Novel Catheter-Based Intramyocardial Injection Platform X-DROP for Endocardial Alginate-Hydrogel Injection in the Treatment of Heart Failure

Abstract

Discussion(0)

Related publications

Feasibility and Safety of Percutaneous Intramyocardial Injection of Alginate-Hydrogel Into the Targeted Endocardial Region in a Porcine Model: A Novel Catheter-Based System X-Drop

CRT-600.07 Feasibility and Safety of Percutaneous Intramyocardial Injection of Alginate-Hydrogel Into the Targeted Endocardial Region in a Porcine Model: A Novel Catheter-Based System X-Drop

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure